A-SEEDS
Matsumoto
About A-SEEDS
A-SEEDS is a biotech company sprouted from Shinshu University, is dedicated to pioneering advanced treatments for life-threatening cancers. Harnessing the potential of non-viral genetic engineering, our cutting-edge immune cell therapy opens up new horizons of hope for patients seeking effective and transformative solutions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $21.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Jul 2025)
- Website: a-seeds.co.jp
- Phone: +81 026-331-5882
Industries & Categories
Biotechnology, Genetics, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/a-seeds-31522 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.